Literature DB >> 6262236

Eosinophil degranulation. Monitoring by interference contrast microscopy.

R Sher, A A Wadee.   

Abstract

A method is described for the quantitative monitoring of human eosinophil degranulation using interference contrast microscopy. Using staphyloccoci as a stimulus, degranulated cells appeared larger than nondegranulating cells, were ameboid in shape and exhibited large nude areas of cytoplasm with prominent nuclei. Granules were observed to marginate along the plasma membrane and discharge into the exterior of the cell. Eosinophils that were not induced to degranulate were spherical in shape and the cytoplasm contained numerous granules that often obscured the nuclei. Pharmacological agents that increase intracellular cAMP prevented degranulation, whereas those that increase cGMP had no effect on degranulation. Colchicine inhibited degranulation but did not interfere with the phagocytosis of staphyloccoci. Endotoxin-activated serum, ECF-A, phytohemagglutinin, concanavalin A, levamisole, and compound 48/80 caused degranulation of eosinophils per se. The presence of disodium cromoglycate prevented this degranulation. Compound 48/80 and disodium cromoglycate had no effect on the level of intracellular cAMP and cGMP.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6262236     DOI: 10.1007/bf00910778

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  30 in total

1.  Effects of levamisole and imidazole on lymphocyte proliferation and cyclic nucleotide levels.

Authors:  J W Hadden; R G Coffey; E M Hadden; E Lopez-Corrales; G H Sunshine
Journal:  Cell Immunol       Date:  1975-11       Impact factor: 4.868

2.  Influence of corticosteroids on human polymorphonuclear leukocyte function in vitro : Reduction of lysosomal enzyme release and superoxide production.

Authors:  I M Goldstein; D Roos; G Weissmann; H B Kaplan
Journal:  Inflammation       Date:  1976-06       Impact factor: 4.092

3.  In vitro studies of immunologically induced secretion of mediators from cells and related phenomena.

Authors:  E L Becker; P M Henson
Journal:  Adv Immunol       Date:  1973       Impact factor: 3.543

4.  Vinblastine: colchicine-like effects on human blood leukocytes during phagocytosis.

Authors:  S E Malawista
Journal:  Blood       Date:  1971-05       Impact factor: 22.113

5.  Site of action of the antiallergic drugs cromoglycate and doxantrazole [proceedings].

Authors:  J C Foreman; M B Hallett; J L Mongar
Journal:  Br J Pharmacol       Date:  1977-03       Impact factor: 8.739

Review 6.  Immunopharmacological aspects of bronchial asthma.

Authors:  R P Orange
Journal:  Clin Allergy       Date:  1973-12

7.  Eosinophil granule lysis in vitro induced by soluble antigen-antibody complexes.

Authors:  G T Archer; M Nelson; J Johnston
Journal:  Immunology       Date:  1969-11       Impact factor: 7.397

8.  Mast cell-mediated reactions of host defense and tissue injury: the regulatory role of eosinophil polymorphonuclear leukocytes.

Authors:  E J Goetzl
Journal:  Inflammation       Date:  1977-09       Impact factor: 4.092

9.  Mast cell degranulation: a comparison of the inhibitory actions of disodium cromoglycate, drugs known to influence the level of intracellular cyclic nucleotide and diisopropylfluorophosphate (DFP).

Authors:  W A Taylor; D Sheldon
Journal:  Int Arch Allergy Appl Immunol       Date:  1974

10.  Ultrastructural observations on the in vitro interaction between rat eosinophils and some parasitic helminths (Schistosoma mansoni, Trichinella spiralis and Nippostrongylus brasiliensis).

Authors:  D J McLaren; C D Mackenzie; F J Ramalho-Pinto
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

View more
  1 in total

1.  Activation and release of enzymes and major basic protein from guinea pig eosinophil granulocytes induced by different inflammatory stimuli and other substances. A histochemical, biochemical, and electron microscopic study.

Authors:  H Popper; G Knipping; B M Czarnetzki; R Steiner; G Helleis; H Auer
Journal:  Inflammation       Date:  1989-04       Impact factor: 4.092

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.